The European Medicines Agency (EMA) will face a rent bill of €347 million even if it leaves London for a European base.02 May 2017
The EMA signed a new lease on its London offices in 2011, running until 2039 with no break clause according to a European Parliament report.
The lease was signed when "a potential exit of the UK from the Union was not foreseeable", the report said.
"However, the costs associated with the relocation would reasonably be expected to be considered in the negotiations on the withdrawal agreement between the Union and the UK government," it said.
A spokesperson for the UK's department for exiting the European Union said the department has no statement on the issue itself, but pointed to a statement by chancellor Philip Hammond in the UK parliament on 18 April.
"The location of the European Union’s agencies is clearly a matter for the European Union. We cannot credibly seek to leave the European Union and at the same time dictate to it where it should locate its agencies," Hammond said.